Latest AlzeCure Pharma News & Updates

See the latest news and media coverage for AlzeCure Pharma. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
AlzeCure Pharma

Swedish pharmaceutical company developing treatments for Alzheimer's and related disorders

alzecurepharma.se
Headquarters
Stockholm, Sweden
Founded year
2016
Company type
Public company
Number of employees
15–50
Industry
Pharmaceuticals

Last updated

Latest news about AlzeCure Pharma

In short: AlzeCure Pharma secured major out-licensing deals for its Alzheimer's platforms and successfully completed several oversubscribed fundraises.

Company announcements

AlzeCure Pharma

AlzeCure Pharma held its annual general meeting on 29 June 2026

The meeting adopted accounts, granted discharge, re-elected directors, and authorized new share issues up to 20% dilution.

Unlock all announcements with a

Media coverage

Dagens industri

AlZeCure Pharma

For the second time in three weeks, the research company Alzecure Pharma surges after a potential mega deal. "This is biology so there are many uncertainties, but so far looks...

Morningstar

Final Outcome of AlzeCure's Rights Issue

THIS PRESS RELEASE DOES NOT CONSTITUTE AN OFFER TO ACQUIRE SECURITIES IN ALZECURE PHARMA AB. STOCKHOLM, SE / ACCESS Newswire / July 2, 2026 ...

Yahoo Finance

Positive Results From The Phase Ib Clinical Study of NeuroRestore ACD856, Under Development for Alzheimer's

STOCKHOLM, SE / ACCESS Newswire / June 16, 2026 / AlzeCure Pharma AB (publ) (STO:ALZCUR)(FRA:AC6), a biotech company that develops candidate drugs for diseases affecting...

Unlock all articles with a

Never miss news about AlzeCure Pharma

Track AlzeCure Pharma and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

AlzeCure Pharma competitors & trending companies

Browse news for competitors to AlzeCure Pharma and other trending companies.